J.P. Morgan Sticks to Its Hold Rating for Roche Holding AG (RHHVF)
J.P. Morgan analyst Richard Vosser maintained a Hold rating on Roche Holding AG today and set a price target of CHF350.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vosser covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Sanofi, and Novo Nordisk. According to TipRanks, Vosser has an average return of 1.1% and a 47.10% success rate on recommended stocks.
In addition to J.P. Morgan, Roche Holding AG also received a Hold from Goldman Sachs’s James Quigley in a report issued today. However, on March 4, Kepler Capital maintained a Buy rating on Roche Holding AG (Other OTC: RHHVF).
The company has a one-year high of CHF374.90 and a one-year low of CHF231.90. Currently, Roche Holding AG has an average volume of 1.11M.
Read More on RHHVF:
Disclaimer & DisclosureReport an Issue
- Genentech reports Phase 2 ZUPREME-1 weight loss trial met primary endpoint
- Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating
- Genentech announces fenebrutinib study met primary endpoint
- Roche genome pricing positive for Illumina, says TD Cowen
- Sarepta announces commercial launch of Elevidys in Japan
